Home
Featured
.
Featured
.
By
Editor / Curator
-
December 19, 2019
Facebook
Twitter
Google+
Pinterest
Linkedin
RELATED ARTICLES
Institutional Analyst Newsletter. Citius (CTXR), GeoVax (GOVX.
Institutional Analyst Newsletter
May 2, 2024
Adding Citius Pharma (CTXR) $0.66 to 2024 Watch List.
2024 Watch List
April 29, 2024
Citius Pharmaceuticals (CTXR) Prospectus, Powerpoint & Fact Sheet.
2024 Watch List
April 27, 2024
GeoVax (GOVX) Launches Vaccine Manufacturing System.
2024 Watch List
April 24, 2024
Experts From Harvard, Scripps Research Institute, the University Hospital Zürich, and the Former Chief Science Officer at Immunogen – Join Tharimmune...
All News
April 17, 2024
Major Mpox Outbreak in the Democratic Republic of Congo.
Mpox
April 3, 2024